Brian Singerman
 Brian Singerman | |
|---|---|
 | |
| Rayuwa | |
| ƙasa | Tarayyar Amurka |
| Karatu | |
| Makaranta | Jami'ar Stanford |
| Sana'a | |
| Sana'a | ɗan kasuwa |
Brian Singerman (an haife shi 1976 or 1977 [1] ) ɗan jari-hujja ne na Amurka kuma ɗan kasuwa. Shi abokin tarayya ne na Founders Fund, wani kamfani mai jari-hujja da ke San Francisco wanda ke da sama da dala biliyan 11 a ƙarƙashin gudanarwa. [2]
Rayuwar farko da ilimi
[gyara sashe | gyara masomin]Singerman ya kammala karatunsa daga Jami'ar Stanford a shekarar 1999 da digirin farko a fannin Kimiyyar Kwamfuta. [3] Bayan Stanford, ya shiga kamfanin yanar gizo na kama-da-wane a can a matsayin injiniyan software. [4]
Sana'a
[gyara sashe | gyara masomin]A shekara ta 2004, Singerman ya shiga Google inda ya shafe shekaru huɗu a matsayin injiniya kuma babban jami'i. A Google, ya kafa shafin yanar gizo na sirri, iGoogle . [5]
A lokacin da yake aiki a Google, Singerman ya fara aikinsa na saka hannun jari, inda ya ƙaddamar da asusun dala miliyan 1 mai suna XGYC Fund, a taƙaice "tsohon Google, Y Combinator." [6]
Asusun Masu Kafawa
[gyara sashe | gyara masomin]A shekara ta 2008, Singerman ya shiga Asusun Founders, inda yake aiki tare da Peter Thiel da Ken Howery . [7] Ya mai da hankali kan kiwon lafiya, fasahar kere-kere, kwamfuta mai sauƙin ɗauka, da kuma na'urorin robot.
Singerman ya kasance daraktan gudanarwa na kamfanoni da dama, ciki har da Affirm, Cloud9, Emerald Therapeutics, The Long-Term Stock Exchange, Oscar Health, da Postmates. Bugu da ƙari, ya yi aiki a matsayin mai lura da harkokin gudanarwa na Airbnb, Forward, da Wish. [8]
A ranar 3 ga Disamba, 2024, Singerman ya sanar da sauya shekarsa zuwa matsayin abokin tarayya na meritus a Asusun Founders, yana shirin ci gaba da zama mai ba da shawara kan dabarun aiki tare da fifita sabon daidaiton aiki da rayuwa. [9]
Manyan jarin da aka zuba
[gyara sashe | gyara masomin]Ɗaya daga cikin manyan jarin da Singerman ya zuba shine na Stemcentrx, wani kamfanin fasahar kere-kere da ke mai da hankali kan magungunan ciwon daji. A watan Afrilun 2016, AbbVie ya sayi Stemcentrx a cikin wata ciniki da ta kai dala biliyan 10.2, wanda hakan ya nuna mafi girman fita daga cikin ayyukansa a tarihin Asusun Tallafawa. Duk da haka, a cikin 2019, AbbVie ya rufe Stemcentrx bayan da babban maganin kansa, Rova-T, ya kasa yin tasiri ga placebo a gwajin asibiti na Mataki na 3.
Ya kuma shiga cikin saka hannun jari a cikin Oculus VR (wanda Facebook ya saya) da Postmates (wanda Uber ya saya). [10]
Rayuwa ta sirri
[gyara sashe | gyara masomin]Singerman yana zaune a San Francisco, California . [11]
Manazarta
[gyara sashe | gyara masomin]- ↑ name="konrad2017">"Move Over, Peter Thiel -- How Brian Singerman Became Founders Fund's Top VC". Forbes. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ name="konrad2017">"Move Over, Peter Thiel -- How Brian Singerman Became Founders Fund's Top VC". Forbes. Retrieved 2 August 2023."Move Over, Peter Thiel -- How Brian Singerman Became Founders Fund's Top VC". Forbes. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ name="Inc.">"Founders Fund: Is This the Most Exclusive Tech Conference Ever". Inc. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.
- ↑ "A look inside Founders Fund, as it closes on $5 billion across two new funds". TechCrunch. Retrieved 2 August 2023.